单位:[1]Department of Thoracic Surgery, Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.华中科技大学同济医学院附属同济医院外科学系胸外科[2]Department of Clinical Medicine, School of Basic Medicine, Zhengzhou University, Zhengzhou, Henan 450000, P.R. China.
Following the publication of the above article, the authors have realized that, on p. 8, some of the supplementary data were cited incorrectly in the main text. In the right-hand column, second paragraph, the sentence beginning on line 5 should have read as follows (changed text is highlighted in bold): "Meanwhile, the expression of miR‑513b‑5p in tumor tissues was decreased and the expression of PRPF39 was increased in tumor tissues with knockout of circ‑G004213 (Fig. S3D and E)." (i.e., the reference to Fig. S3C and D was incorrect.). The authors regret their oversight in failing to correct the inaccurate citation of the data in the paper, are grateful to the Editor for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 23: Article no. 421, 2021; DOI: 10.3892/mmr.2018.12060].
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区肿瘤学
最新[2025]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区肿瘤学
第一作者:
第一作者单位:[1]Department of Thoracic Surgery, Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
推荐引用方式(GB/T 7714):
Liao Yuan-Fan,Yin Sui,Chen Zi-Qi,et al.[Corrigendum] Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer.[J].Molecular medicine reports.2021,24(4):doi:10.3892/mmr.2021.12359.
APA:
Liao Yuan-Fan,Yin Sui,Chen Zi-Qi,Li Fan&Zhao Bo.(2021).[Corrigendum] Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer..Molecular medicine reports,24,(4)
MLA:
Liao Yuan-Fan,et al."[Corrigendum] Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer.".Molecular medicine reports 24..4(2021)